Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

97.35
+1.041.08%
Volume:86.72K
Turnover:8.36M
Market Cap:6.32B
PE:-6.91
High:97.35
Open:96.31
Low:95.49
Close:96.31
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:0.48
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-606.52
PE(LYR):-207.13

Loading ...

Mirum Q2 FY26 Operating Loss Widens to $42.54 Million; Net Sales Rise 37.91% to $176.24 Million

Reuters
·
Aug 06

Mirum Pharmaceuticals Q2 Adj. EPS $(1.06) Misses $(0.68) Estimate, Sales $176.200M Beat $166.122M Estimate

Benzinga Earnings
·
Aug 06

Mirum Pharmaceuticals Q2 Operating Income USD -42.537 Million

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals Inc Expected to Post a Loss of 68 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Mirum Pharmaceuticals Updates Financial Calendar with Quarterly Results Call

Reuters
·
Jul 30

Mirum treatment of primary sclerosing cholangitis granted FDA orphan status

TIPRANKS
·
Jul 22

Arcutis Appoints Mirum CEO Chris Peetz to Board

Reuters
·
Jul 16

Mirum Grants Inducement Equity Awards to 6 New Hires, Including 6,300 Stock Options Priced at $122.13

Reuters
·
Jul 14

Mirum Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 14

Mirum CFO Eric Bjerkholt Disposes of Common Shares Worth $609,156.6

Reuters
·
Jul 09

FDA Priority Review For Zilurgisertib Could Be A Game Changer For Mirum Pharmaceuticals (MIRM)

Simply Wall St.
·
Jul 06

Mirum SVP, Global Controller Jolanda Howe Disposes of 2,721 Common Shares Worth $326,520

Reuters
·
Jul 03

U.S. Research Roundup- Adobe, Nike, Watts Water Technologies

Reuters
·
Jul 02

Mirum Pharmaceuticals Inc : JP Morgan Raises Target Price to $125 from $115

THOMSON REUTERS
·
Jul 02

Mirum SVP, Global Controller Jolanda Howe sells 2,594 shares for $264,458.3

Reuters
·
Jun 19

Mirum Pharmaceuticals holds annual shareholder meeting

Reuters
·
Jun 19

Mirum Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Jun 15

Mirum Pharmaceuticals price target raised to $146 from $140 at Citizens

TIPRANKS
·
Jun 15

Mirum Pharmaceuticals, Incyte Say Zilurgisertib Showed Meaningful Reductions in Heterotopic Ossification Lesion Volume During Clinical Trial

MT Newswires Live
·
Jun 15